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We found a prevalence of 18% for enterotoxin
gene–carrying (cpe+) Clostridium perfringens in the feces
of healthy food handlers by PCR and isolated the organism
from 11 of 23 PCR-positive persons by using hydrophobic
grid membrane filter-colony hybridization. Several different
cpe genotypes were recovered. The prevalence was 3.7%
for plasmidial IS1151-cpe, 2.9% for plasmidial IS1470-like-
cpe, 0.7% for chromosomal IS1470-cpe, and 1.5% for
unknown cpe genotype. Lateral spread of cpe between C.
perfringens strains was evident because strains from the
same person carried IS1470-like cpe but shared no genet-
ic relatedness according to pulsed-field gel electrophoresis
analysis. Our findings suggest that healthy humans serve
as a rich reservoir for cpe+ C. perfringens type A and may
play a role in the etiology of gastrointestinal diseases
caused by this organism. The results also indicate that
humans should be considered a risk factor for spread of C.
perfringens type A food poisoning and that they are a
possible source of contamination for C. perfringens type A
food poisoning.
C
lostridium perfringens is classified into 5 types (A–E)
on the basis of its ability to produce >1 of the major
lethal toxins α, β, ε, and ι (1). Enterotoxin (CPE)-produc-
ing (cpe+) C. perfringens type A is reported continuously
as 1 of the most common food poisoning agents worldwide
(2–4). An increasing number of reports also implicate the
organism in 5%–15% of antimicrobial drug–associated
diarrhea (AAD) and sporadic diarrhea (SD) cases in
humans as well as diarrhea cases in animals (1,5–9). Most
food poisoning strains studied to date carry cpe in their
chromosomes; isolates from AAD and SD cases bear cpe
in a plasmid (10,11). Furthermore, genetic studies have
shown that in C. perfringens strains with the chromosoma-
lly located cpe, IS1470 sequences are found upstream and
downstream of cpe (12,13). However, in strains with cpe in
the plasmid, 2 different genetic arrangements (either
IS1151 or IS1470-like sequences) have been recognized
downstream of cpe (11,14).
Why C. perfringens strains with cpe located on chro-
mosomes or plasmids cause different diseases has not been
satisfactorily explained. However, the relatively greater
heat resistance of the strains with chromosomally located
cpe is a plausible explanation for these strains’ survival in
cooked food, thus causing instances of food poisonings
(15). The presence of C. perfringens strains with chromo-
somally located cpe in 1.4% of American retail food indi-
cates that these strains have an access to the food chain
(16). The sources and routes of contamination are unclear.
An explanation for the strong association between C.
perfringens strains with plasmidially located cpe and cases
of AAD and SD disease may be in vivo transfer of the cpe
plasmid to C. perfringens strains of the normal intestinal
microbiota (17). Thus, a small amount of ingested cpe+ C.
perfringens would act as an infectious agent and transfer
the cpe plasmid to cpe– C. perfringens strains of the nor-
mal microbiota. This process would result in the persist-
ence of cpe+  C. perfringens in the intestines. Chronic
exposure to CPE would explain the severity and long dura-
tion of symptoms (17). Conjugative transfer of the cpe
plasmid has been demonstrated in vitro (18), but currently
no data exist on lateral transfer of cpe in vivo, and whether
cpe+ strains that cause AAD and SD are resident in the
gastrointestinal tract or acquired before onset of the dis-
ease is unknown.
Although the ubiquitous distribution of C. perfringens in
nature is well documented, the epidemiology of cpe+ strains
has not yet been established. Less than 5% of global
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the prevalence of different cpe genotypes in specific eco-
logic niches is not known. In this study, healthy persons
were screened for fecal carriage of cpe, and cpe+ strains
were further isolated by using hydrophobic grid membrane
filter-colony hybridization. The cpe genotype and location
of cpe were determined from strains by detecting different
insertion sequence (IS) elements attached to cpe (plasmid
types IS1151-cpe and IS1470-like-cpe and chromosomal
type IS1470-cpe). The genetic relationship between cpe+
and cpe– C. perfringens isolates obtained from cpe carriers
was assessed with pulsed-field gel electrophoresis (PFGE).
Materials and Methods
Fecal Samples
A total of 136 fecal samples, 102 (75%) from female
food handlers and 34 (25%) from male food handlers, were
collected from food handlers in southern Finland during
summer 2003. These persons reported no gastrointestinal
symptoms at the time of sampling. Their ages ranged from
15 to 65 years (mean 30 years, median 24 years). The sam-
ples were kept at −70°C until investigated.
Detection and Isolation
Each fecal sample (1 g) was divided into 2 tubes that
contained freshly prepared thioglycollate (40 mL) (Oxoid,
Basingstoke, UK). One tube was heated at 75°C for 20 min;
the other was left unheated. After anaerobic incubation at
37°C for 20–22 h, the presence of cpe in each tube was
determined by nested PCR (19). Persons with a cpe-posi-
tive fecal sample are hereafter referred to as cpe carriers.
Hydrophobic grid membrane filter-colony hybridiza-
tion (HGMF-CH) (20) was used to isolate cpe+ C. perfrin-
gens from  cpe carriers. In addition to probe-positive
colonies, those showing no hybridization signals but hav-
ing a typical color for C. perfringens colonies (usually
black, occasionally gray or grayish yellow) were isolated
from each sample to obtain a collection of both cpe+ and
cpe– C. perfringens from a single sample and to further
study the genetic relatedness of these isolates by PFGE
(see below).
The isolates were subjected to PCR to determine the
toxinotype (A–E) and the presence of cpe (21). C. perfrin-
gens strains NCTC 8239, ATCC 3626, CCUG 2036, CCUG
2037, and CCUG 44727 were used as positive controls.
Molecular Typing
C. perfringens isolates that possessed cpe were further
studied by PCR to determine the cpe genotype of the
strain. Total DNA was isolated by using Advamax beads
(Edge Biosystems, Gaithersburg, MD, USA) according to
the manufacturer’s instructions. IS elements downstream
of  cpe that determine the cpe genotype (IS1151-cpe,
IS1470-like-cpe, or IS1470-cpe) of each isolate were char-
acterized by using primers and protocols described in
Table 1. The location of cpe (plasmid or chromosome) was
concluded according to the genotyping results (Table 1).
C. perfringens isolates were then typed by PFGE with
ApaI and SmaI (New England Biolabs, Beverly, MA,
USA) to study the genetic relationships between isolates
(25). PFGE profiles were analyzed visually and with a
computer software program (Bionumerics, version 4.5;
Applied Maths, Kortrijk, Belgium). The similarities
between macrorestriction patterns (MRP) were expressed
by Dice coefficient correlation, and clustering by the
unweighted pair-group method with arithmetic averages
was used to construct a dendrogram.
Cytotoxicity Test on Vero Cells
To test the capability of cpe+ strains to produce CPE,
1–3 cpe+ isolates representing each MRP were sporulated
(26). The final culture in modified Duncan-Strong medium
(Sigma-Aldrich Chemie, Steinheim, Switzerland) was
examined by phase-contrast microscopy to confirm the
sporulation of the strain. The culture was then sonicated
until >95% of the spores were free, as determined by
phase-contrast microscopy. The culture was centrifuged at
1,500× g for 25 min at 4°C, and cytotoxicity of the super-
natant was tested with a Vero cell assay according to
Sandvig and Olsnes (27). The assay monitors the inhibi-
tion of protein synthesis in Vero cells after addition of
toxic proteins, including CPE. The Vero cells were grown
in a minimal essential medium (Gibco BRL, Paisley, UK)
supplemented with 10% fetal calf serum.
The supernatant was precipitated in 80% saturated
ammonium sulfate and kept at 4°C before the Vero cell
assay. The strain was defined as producing CPE when the
inhibition of protein synthesis of Vero cells was >20%.
Results
Detection and Isolation
The gene encoding for cpe was detected in the feces of
25 food handlers (18%). For 23 samples (92%), the heated
tube showed the positive result, and for 3 of them the
unheated tube also yielded a positive PCR result. For 2
samples, only the unheated tube showed a positive PCR
result. No association between gender or age and carrier
status of cpe was found (Table 2).
The HGMF-CH method was used to determine whether
cpe+ C. perfringens was present in 23 persons; isolation
was successful from 11 persons. The average number of
cpe+ C. perfringens isolates carried by these persons was
2.5 × 102 CFU/g. In 10 of these persons, cpe– C. perfrin-
gens was also recovered; the average number was 1.8 ×
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fringens formed a 10- to 1,000-fold majority of the C. per-
fringens population. In 1 person, only cpe+ C. perfringens
isolates were recovered. A total of 77 C. perfringens iso-
lates (average of 7 isolates per person) were recovered; all
possessed the gene encoding for the α toxin only, which
signified that they belonged to type A (online Appendix
Table, available from http://www.cdc.gov/ncidod/
EID/vol12 no11/06-0478_appT.htm). Of these, 36 isolates
were positive for cpe (Appendix Table).
Molecular Typing
When the relative prevalence of different cpe genotypes
was determined with PCR, strains representing the IS1151-
cpe type were found in 5 persons (3.7%) and strains repre-
senting the IS1470-like-cpe type were found in 4 persons
(2.9%), findings that indicated that all of these persons car-
ried C. perfringens strains with plasmidially located cpe. A
strain with chromosomally located cpe, representing the
IS1470-cpe type, was detected in 1 person (0.7%).
Furthermore,  cpe+  C. perfringens strains representing
none of the aforementioned types, referred to as cpe+
strains with an unknown genetic arrangement downstream
of  cpe, were observed in 2 persons (1.5%) (Appendix
Table) (Figure 1).
In PFGE analysis, all isolates were typeable with SmaI
restriction enzyme, and all but 2 isolates were typeable
with ApaI. The discriminatory power was equal with both
enzymes used, which showed a high genetic diversity
among C. perfringens. PFGE analysis showed 1–5 differ-
ent MRPs in each person, with cpe+ and cpe– isolates gen-
erally being unrelated to each other. However, in 1 case, 2
isolates (CPI 57–1 and CPI 57–2) from the same person
showed identical MRPs with both restriction enzymes, the
former being cpe+ and the latter cpe– (Appendix Table;
Figure 2). In 8 of 11 persons, cpe+ isolates with similar
MRPs were identified, whereas 3 persons carried cpe+ iso-
lates with 2 different MRPs. In 2 of these persons (num-
bers 18 and 57), both MRPs represented the same cpe
genotype (IS1470-like-cpe); the third person (number 75)
had MRPs with different cpe genotypes (IS1470-like-cpe
and IS1151-cpe) (Appendix Table).
Cytotoxicity Test on Vero Cells
Successful sporulation was achieved with isolates rep-
resenting 9 different MRPs. In 8 (89%) of these MRPs,
>20% inhibition of protein synthesis was detected in Vero
cells, which suggested CPE production of the strain
(Table 3).
Discussion
We report the first in-depth study of the fecal carriage
of cpe+ C. perfringens by healthy humans, which showed
that the organism is widely distributed in this ecologic
niche. By using the novel HGMF-CH method, we demon-
strated that low numbers of cpe+ C. perfringens strains are
frequently present among the dominant cpe– C. perfrin-
gens. HGMF-CH proved invaluable in the isolation of
cpe+ C. perfringens; in all instances, when both cpe+ and
cpe– C. perfringens were isolated, the former existed as a
minority and thus would have been missed by convention-
al isolation methods.
Healthy persons are a rich reservoir for cpe+ C. per-
fringens; type A strains representing several different cpe
genotypes (strains with plasmidially located IS1470-
like–cpe or IS1151-cpe and chromosomally located
IS1470-cpe) as well as type A strains with unrecognized
genetic arrangement attached to cpe were present. That
IS1151-cpe was the most prevalent and IS1470-cpe repre-
sented the minority of the cpe genotypes are findings in
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fringens strains with plasmidially located cpe are more
common in nature than cpe+ C. perfringens strains with
chromosomally located cpe (28). The presence of strains
with unrecognized genetic arrangement attached to cpe
reflects the wide genetic variety of cpe+ strains. Because
production of CPE was demonstrated in 1 of these cpe+
strains with an unknown cpe genotype, the gene was
apparently intact and functional.
The presence of cpe+ C. perfringens type A strain with
chromosomally located cpe and a full capacity to produce
CPE in the feces of healthy food handlers indicates that
human handling of food should be considered a risk factor
for contamination. C. perfringens type A food poisoning
typically follows from the ingestion of cpe+ C. perfrin-
gens vegetative cells formed in food during storage and
serving (29). The low numbers of cpe+ C. perfringens
spores present in the feces of the person handling the food
may be transferred to the food. Under favorable condi-
tions, cpe+ strains with chromosomally located cpe will
easily survive and multiply during food processing and
cause food poisoning because they survive broader tem-
perature ranges during growth and maintenance phases
than other C. perfringens strains (15,30).
Evidence of in vivo horizontal transfer of cpe between
C. perfringens strains was obtained in the PFGE analysis.
First, in 2 persons (numbers 18 and 57), IS1470-like-cpe
was observed in strains with no genetic relatedness, which
indicated lateral spread of IS1470-like-cpe (Appendix
Table). In vitro conjugative transfer of the cpe plasmid has
been demonstrated with strain F4969 carrying IS1470-
like-cpe (18,24), which supports our findings. Second, the
evidence of in vivo horizontal transfer of cpe was further
strengthened by observing a loss or acquisition of IS1470-
like-cpe in 1 strain (MRP 15) (Appendix Table). In this
case, the isolate CPI 57–1 carried IS1470-like-cpe, where-
as CPI 57–2 was lacking in the same element; these strains
were nevertheless isolated from the same person and
shared an identical MRP. A potential donor or recipient
strain (MRP 13 and 13b) was demonstrated from the same
sample, which carried IS1470-like-cpe but shared no
genetic relatedness to CPI 57–1 (Appendix Table) (Figure
2). All IS1151-cpe isolates from the same persons shared
identical MRPs; thus, no evidence for in vivo lateral trans-
fer of IS1151-cpe was observed.
Finally, our study provides a new insight into the patho-
genesis of AAD and SD caused by cpe+ C. perfringens
type A. These diseases have been speculated to result from
the ingestion of small numbers of cpe+ strains, which
transfer the cpe plasmid to cpe– C. perfringens strains
present in the normal intestinal microbiota (17). Our
results support this theory because we found small num-
bers of cpe+ C. perfringens type Awith plasmidially locat-
ed  cpe in the human gastrointestinal tract as well as
evidence for the lateral spread of cpe. Our findings there-
fore indicate that AAD or SD caused by cpe+ C. perfrin-
gens type Amay occur as an endogenous infection, present
in the gastrointestinal tract and causing the disease after
exposure to antimicrobial drugs or other predisposing fac-
tors. However, the capacity of these cpe+ strains to persist
in the gastrointestinal tract remains unknown; as does how
these strains find their way to the gastrointestinal tract.
Nevertheless, because they are apparently common in
human feces, cpe+ strains are presumably acquired from
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Figure 1. PCR analysis determining the genotype of enterotoxin
gene-carrying  Clostridium perfringens type A isolates obtained
from healthy persons. All 4 strains are studied with 3 different
primer sets, described in Table 1. For A, B, C and D, the isolate
represents genotype IS1470-like-cpe, IS1151-cpe, IS1470-cpe, or
unknown genotype, respectively.
Figure 2. Pulsed-field gel electrophoresis analysis and determination of the cpe genotype of Clostridium perfringens isolates obtained
from a healthy person. ND, not determined.the environment. The question then arises whether these
cpe+ strains are ingested with food, which would indicate
that AAD and SD caused by cpe+ C. perfringens type A
are foodborne.
In conclusion, healthy humans serve as a rich reservoir
for cpe+ C. perfringens type A strains and may play an
important role in gastrointestinal diseases caused by this
pathogen. Humans should therefore be considered a risk
factor for spread of C. perfringens type A food poisoning.
Future studies to determine the presence of different cpe
genotypes in other ecologic niches are warranted to eluci-
date the epidemiology of this major pathogen.
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